ライフサイエンスコーパス: mature teratoma

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 resection of viable disease (GCT other than mature teratoma).

2 est and intrinsic chemotherapy resistance of mature teratomas.

3 1.34 [mean +/- SD]) was higher than that of mature teratoma (1.38 +/- 0.71) and necrosis or scar (1.

4 ely concordant allelic loss patterns between mature teratoma and all of the other germ cell tumor com

5 y analysis, we investigated the clonality of mature teratoma and its relationship to other components

6 the kinetic rate constants K1 and K between mature teratoma and necrosis or scar as follows: K1, 0.1

7 All 16 patients had mature teratoma as one component of their mixed germ cel

8 al interpretation nor SUVlean differentiated mature teratoma from necrosis or scar, there were statis

9 PC-RPLND pathology revealed mature teratoma in 178 patients (85%), immature teratoma

10 l tissue, with only necrosis found in 10 and mature teratoma in one.

11 hat the stromal cells adjacent to metastatic mature teratoma in postchemotherapy lymph node specimens

12 teratoma of the ovary (six mature) and one a mature teratoma in the mediastinum; five of five tumors

13 Metastatic mature teratoma is often present in postchemotherapy sur

14 Malignant transformation of mature teratomas may be predicted by preoperative squamo

15 nd risk factors for relapse of children with mature teratoma (MT) and immature teratoma (IT) to assis

16 neoplastic cysts (n = 5; two endometriomas); mature teratoma (n = 3); hydrosalpinx (n = 2); fibroma (

17 could easily be differentiated visually from mature teratoma (n = 6) and necrosis or scar (n = 10).

18 onents were seen in 10 of 14 tumors in which mature teratoma showed loss of heterozygosity.

19 Fourteen of 16 mature teratomas showed allelic loss in at least one of

20 The frequency of allelic loss in mature teratoma was 50% (7 of 14) with D1S508, 33% (5 of

21 toneal lymph nodes that contained metastatic mature teratoma with "fibrosis" to determine the reactiv

22 Our data support the common clonal origin of mature teratoma with other components of malignant mixed

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。